Home › Neuroendocrine Carcinoma › Michigan › Grand Rapids
Neuroendocrine Carcinoma clinical trials in Grand Rapids, MI
3 studies for Neuroendocrine Carcinoma are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
RecruitingPhase 1/2
- Crinetics Study Site, Grand Rapids
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RecruitingPhase 1/2
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecruitingPhase 1/2
- START Midwest, Grand Rapids
Neuroendocrine Carcinoma trials in other cities
- Houston, TX6 studies
- New York City, NY6 studies
- Arlington, VA5 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Washington, DC4 studies
- St. Louis, MO3 studies
- Columbus, OH3 studies
- Atlanta, GA3 studies
- New Haven, CT3 studies
- Denver, CO3 studies
- Nashville, TN3 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer44 studies
- Colorectal Cancer40 studies
- Cancer (all types)28 studies
- Breast Cancer26 studies
- Ovarian Cancer24 studies
- Metastatic Cancer22 studies
- Prostate Cancer19 studies
- Endometrial Cancer18 studies
- Stomach Cancer18 studies
- Pancreatic Cancer18 studies
- Melanoma17 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.